These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4296232)

  • 1. The stability of the protective antigen and histamine-sensitizing factor of Bordetella pertussis to acid and alkali.
    Jakus CM; McClure L; Wardlaw AC
    Can J Microbiol; 1968 Feb; 14(2):147-51. PubMed ID: 4296232
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.
    Munoz J; Hestekin BM
    J Bacteriol; 1966 Jun; 91(6):2175-9. PubMed ID: 4287581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunobiological properties of Bordetella pertussis].
    Kopacka B
    Pediatr Pol; 1972; 47(3):361-70. PubMed ID: 4336329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationship of the sensitizing and protective properties of pertussis antigens].
    Lebedev VS; Selezneva VP; Moshiashvili IIa; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):83-7. PubMed ID: 6285648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the histamine-sensitizing factor of Bordetella pertussis by density gradient centrifugation.
    Griffiths BW; Mason MA
    Can J Microbiol; 1968 May; 14(5):525-8. PubMed ID: 4173097
    [No Abstract]   [Full Text] [Related]  

  • 7. Interconnexion between the protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    JOO I; PUSZTAI Z
    Nature; 1960 Oct; 188():331-2. PubMed ID: 13790658
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunogenicity and toxicity of soluble trichloroacetic acid precipitate from pertussis microbes and its fractions].
    Bazhanova IG; Gladkaia VI; Liashenko VA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):128-32. PubMed ID: 202117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of agglutinogenic types of Bordetella pertussis in the assay of pertussis vaccines.
    Cameron J
    Prog Immunobiol Stand; 1967; 3():302-8. PubMed ID: 4314430
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccine from the cell fragments of Bordetella pertussis. I. Protective, sensitizing properties and morphological characteristics of the vaccine].
    Zakharova MS; Shirko GN; Gureeva AA; Pereverzev NA
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):103-8. PubMed ID: 64095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation from Bordetella pertussis of protective antigen free from toxic activity and histamine sensitizing factor.
    Nagel J
    Nature; 1967 Apr; 214(5083):96-7. PubMed ID: 4291816
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bordetella pertussis spheroplasts. 4. The protective, histamine-sensitizing and toxic action of spheroplasts and spheroplast cell walls].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Mar; 219(3):358-65. PubMed ID: 4122376
    [No Abstract]   [Full Text] [Related]  

  • 14. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
    Sato Y; Sato H
    Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP; Dolby JM
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract]   [Full Text] [Related]  

  • 16. [The presence of a substance complementary to the agglutinogen of B. pertussis in the serum of normal mice].
    Kuznetsov EA
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):81-4. PubMed ID: 4337416
    [No Abstract]   [Full Text] [Related]  

  • 17. Pertussis antigens--screening models on toxicity.
    Ronneberger H; Blackkolb F; Guthöhrlein G
    Arch Toxicol Suppl; 1982; 5():129-32. PubMed ID: 6285854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the relationship between histamine sensitizing factor and mouse protective antigen.
    Niwa M; Hiramatsu T; Kawasaki N; Kuwajima Y
    Jpn J Med Sci Biol; 1965 Jun; 18(3):175. PubMed ID: 4285053
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in Bordetella pertussis.
    Cameron J
    J Pathol Bacteriol; 1967 Oct; 94(2):367-74. PubMed ID: 4294462
    [No Abstract]   [Full Text] [Related]  

  • 20. Histamine-sensitising factor of Bordetella pertussis differentiated from immunogens by neutralisation and passive protection tests.
    Preston NW; Garrity P
    J Pathol Bacteriol; 1967 Apr; 93(2):483-92. PubMed ID: 4293307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.